Fig 1: Silencing of Hax-1 attenuates LPA and FBS stimulated invasive migration of SKOV3 cells.(A) Transient silencing of Hax-1 was carried out by transfecting SKOV3 cells with vectors encoding shRNA specific for Hax-1 (sh-Hax 1 & sh-Hax #3) or scrambled shRNA control for 48 hours (sh-NS). These transfectants were unstimulated (SS), stimulated with LPA (20 μM), or FBS (10%) and their migratory responses were monitored as described under Materials and Methods. At 24 hours following stimulation, images were obtained from random fields of view at 10X magnification. The images shown are representative of three independent experiments, each performed with triplicate fields of view. (B) Cell migration profiles were quantified by enumerating the migrated cells in a minimum of three different fields. Results are presented as the number of migrated cells per field and the bars represent mean ± SEM from there independent experiments. Silencing of endogenous Hax-1 was monitored by immunoblot analysis using antibodies to Hax-1 (inset). The blot was stripped and reprobed with antibodies to GAPDH to monitor equal loading of protein.
Fig 2: Expression of Rac1-interacting domains of Hax-1 inhibits the migration of SKOV3.(A) SKOV3 control cells transfected with the empty pcDNA3.1+ vector (VC) and SKOV3 cells transiently transfected with HA-epitope tagged domains of Hax-1, Hax-D1, Hax-D2, Hax-D3, Hax-D4, and Hax-D5 (denoted as D1, D2, D3, D4, and D5 respectively), were utilized to analyze the role of Hax-1 domains on cell migration. At 24 hours after transfection, 0.5 μM Mitomycin-C was added to the transfectants (5×105/dish) to prevent cell division. Linear scratch wounds were made with 200 μl pipette tips across the monolayer of cells in the respective dishes to initiate the wound-healing assay. At 0 hour, fields of view (10X) were selected at random, photographed and marked for re-identification. The identical fields were re-imaged after 24 hours of incubation. The images presented are representative of three independent experiments, each performed with triplicate fields of view. (B) Percentage of wound closure and the migration inhibition percentage were calculated based on the migration of the transfectants expressing vector control and the respective domains. The statistical significance was assessed using students-t test. * p<0.05. Error bars are presented as mean ± SEM for triplicate experiments. (C) Expression of the respective Hax-1 domains was monitored by immunostaining with HA-epitope antibody. Three different fields were viewed and three independent experiments were performed. Fluorescent micrographs were collected with a Leica SP2 MP Confocal microscope using 63x Plan APO 1.4 NA oil immersion objective. The results presented here are from a typical experiment and the scale bar is 10 μm for all the images. (D) Expression of HA-tagged Hax-D1-D5 domains (labeled as D1, D2, D3, D4, D5) were monitored along with vector control (VC) by immunoblot analysis using lysates (50 μg) derived from the respective transfectants. Lysates were resolved in 15% SDS-PAGE gels and immunoblotted with an antibody against HA-epitope. The blot was stripped and reprobed with GAPDH antibody to monitor equal loading of protein. The HA-epitope reactive bands were quantified and plotted as percent expression over GAPDH levels (mean ± SEM; n = 3).
Fig 3: Hax-1 interacts with cortactin and Rac1 via distinct regions.(A) Hax-D1, Hax-D2, Hax-D3, Hax-D4, and Hax-D5 domain constructs, labeled D1, D2, D3, D4, and D5, comprising of 56 consecutive amino acids, were cloned by PCR methods in pGEX 5x-1 vector. (B, C) The GST-D1-D5 Sepharose beads were prepared using protocols as discussed under Materials and Methods section from the GST-Hax-D1-D5 domain constructs. 2 mg of SKOV3 lysate protein obtained using previously published procedures were incubated with the GST- D1, GST-D2, GST-D3, GST-D4, and GST-D5 Sepharose beads for 4 hours at 4°C. The beads were washed five times with chilled GST-lysis buffer, and eluted in SDS sample-loading buffer. The co-precipitated Rac1 or cortactin along with the putative interacting domain, with Vector control (VC) and lysate input control (L) were identified by immunoblot analysis. Results presented are from a typical experiment and each experiment was carried out at least thrice. Binding percentage of cortactin (Figure 4B) and Rac1 (Figure 4C) were assessed and the error bars are presented as mean ± SEM. The statistical significance was assessed using one-tailed t-test. * p<0.05.
Supplier Page from OriGene Technologies for HAX1 Human shRNA Plasmid Kit (Locus ID 10456)